RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Atossa Therapeutics Stock

Atossa Therapeutics Equity 2024

Atossa Therapeutics Equity

91.02 M USD

Ticker

ATOS

ISIN

US04962H5063

WKN

A2JJ99

In 2024, Atossa Therapeutics's equity was 91.02 M USD, a -22.87% increase from the 118 M USD equity in the previous year.

Atossa Therapeutics Aktienanalyse

What does Atossa Therapeutics do?

Atossa Therapeutics Inc. is a biopharmaceutical company based in Seattle, USA, specializing in the development of therapies for the treatment of breast cancer and other breast diseases. Atossa Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Atossa Therapeutics's Equity

Atossa Therapeutics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Atossa Therapeutics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Atossa Therapeutics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Atossa Therapeutics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Atossa Therapeutics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Atossa Therapeutics stock

What is the equity of Atossa Therapeutics this year?

Atossa Therapeutics has equity of 91.02 M USD this year.

What was the equity of Atossa Therapeutics compared to the previous year?

The equity of Atossa Therapeutics has increased/decreased by -22.87% decreased compared to the previous year.

What impact does a high equity have on investors of Atossa Therapeutics?

A high equity is advantageous for investors of Atossa Therapeutics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Atossa Therapeutics?

A low equity can be a risk for investors of Atossa Therapeutics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Atossa Therapeutics affect the company?

An increase in equity of Atossa Therapeutics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Atossa Therapeutics affect the company?

A reduction in equity of Atossa Therapeutics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Atossa Therapeutics?

Some factors that can affect the equity of Atossa Therapeutics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Atossa Therapeutics so important for investors?

The equity of Atossa Therapeutics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Atossa Therapeutics take to change the equity?

To change equity, Atossa Therapeutics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Atossa Therapeutics pay?

Over the past 12 months, Atossa Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Atossa Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Atossa Therapeutics?

The current dividend yield of Atossa Therapeutics is .

When does Atossa Therapeutics pay dividends?

Atossa Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Atossa Therapeutics?

Atossa Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Atossa Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Atossa Therapeutics located?

Atossa Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Atossa Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Atossa Therapeutics from 11/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/25/2024.

When did Atossa Therapeutics pay the last dividend?

The last dividend was paid out on 11/25/2024.

What was the dividend of Atossa Therapeutics in the year 2023?

In the year 2023, Atossa Therapeutics distributed 0 USD as dividends.

In which currency does Atossa Therapeutics pay out the dividend?

The dividends of Atossa Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Atossa Therapeutics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Atossa Therapeutics

Our stock analysis for Atossa Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Atossa Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.